- Home
- AQST vs CPS Comparison
AQST vs CPS Comparison
Compare AQST & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- CPS
- Stock Information
- Founded
- AQST 2004
- CPS 1960
- Country
- AQST United States
- CPS United States
- Employees
- AQST N/A
- CPS N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- AQST Health Care
- CPS Consumer Discretionary
- Exchange
- AQST Nasdaq
- CPS Nasdaq
- Market Cap
- AQST 390.4M
- CPS 462.2M
- IPO Year
- AQST 2018
- CPS N/A
- Fundamental
- Price
- AQST $5.84
- CPS $36.25
- Analyst Decision
- AQST Strong Buy
- CPS Hold
- Analyst Count
- AQST 7
- CPS 1
- Target Price
- AQST $10.29
- CPS $12.00
- AVG Volume (30 Days)
- AQST 3.6M
- CPS 169.7K
- Earning Date
- AQST 11-03-2025
- CPS 10-30-2025
- Dividend Yield
- AQST N/A
- CPS N/A
- EPS Growth
- AQST N/A
- CPS N/A
- EPS
- AQST N/A
- CPS 1.65
- Revenue
- AQST $44,132,000.00
- CPS $2,719,148,000.00
- Revenue This Year
- AQST N/A
- CPS $2.31
- Revenue Next Year
- AQST $51.50
- CPS $3.69
- P/E Ratio
- AQST N/A
- CPS $22.18
- Revenue Growth
- AQST N/A
- CPS N/A
- 52 Week Low
- AQST $2.12
- CPS $10.38
- 52 Week High
- AQST $6.43
- CPS $40.67
- Technical
- Relative Strength Index (RSI)
- AQST 62.29
- CPS 49.42
- Support Level
- AQST $5.47
- CPS $35.74
- Resistance Level
- AQST $5.93
- CPS $37.36
- Average True Range (ATR)
- AQST 0.36
- CPS 1.42
- MACD
- AQST 0.01
- CPS -0.58
- Stochastic Oscillator
- AQST 62.43
- CPS 15.02
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.